Edition:
United States

People: C R Bard Inc (BCR)

BCR on New York Consolidated

243.24USD
21 Feb 2017
Change (% chg)

$0.83 (+0.34%)
Prev Close
$242.41
Open
$241.99
Day's High
$245.42
Day's Low
$241.92
Volume
562,231
Avg. Vol
571,832
52-wk High
$245.42
52-wk Low
$188.71

DeFord, John 

Dr. John A. DeFord, Ph.D., is Senior Vice President-Science, Technology and Clinical Affairs of Company. He joined Bard in 2004 as Vice President, Science & Technology after serving as Managing Director with Early Stage Partners, LLP (ESP), a venture capital fund, from 2002 until 2004. Before joining ESP he was President and CEO of Cook Incorporated, a privately-held medical device company. He was promoted to Senior Vice President-Science, Technology & Clinical Affairs in 2007.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Timothy Ring

11,744,800

John Weiland

6,920,670

James Beasley

3,827,980

Timothy Collins

3,909,070

John Groetelaars

--

Christopher Holland

3,652,540
As Of  30 Dec 2015